PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL

Available from:

Phebra Pty Ltd

Pharmaceutical form:

Injection, intravenous infusion

Composition:

Excipient Ingredients: water for injections

Administration route:

Intravenous

Units in package:

10mL x 10

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Product summary:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

1991-10-14